Optimal timing of same-admission orthotopic heart transplantation after left ventricular assist device implantation.

Autor:	Gulati G; Gunsagar Gulati, David Ouyang, Dipanjan Banerjee, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States., Ouyang D; Gunsagar Gulati, David Ouyang, Dipanjan Banerjee, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States., Ha R; Gunsagar Gulati, David Ouyang, Dipanjan Banerjee, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States., Banerjee D; Gunsagar Gulati, David Ouyang, Dipanjan Banerjee, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.
Jazyk:	angličtina
Zdroj:	World journal of cardiology [World J Cardiol] 2017 Feb 26; Vol. 9 (2), pp. 154-161.
DOI:	10.4330/wjc.v9.i2.154
Abstrakt:	Aim: To investigate the impact of timing of same-admission orthotopic heart transplant (OHT) after left ventricular assist device (LVAD) implantation on in-hospital mortality and post-transplant length of stay. Methods: Using data from the Nationwide Inpatient Sample from 1998 to 2011, we identified patients 18 years of age or older who underwent implantation of a LVAD and for whom the procedure date was available. We calculated in-hospital mortality for those patients who underwent OHT during the same admission as a function of time from LVAD to OHT, adjusting for age, sex, race, household income, and number of comorbid diagnoses. Finally, we analyzed the effect of time to OHT after LVAD implantation on the length of hospital stay post-transplant. Results: Two thousand and two hundred patients underwent implantation of a LVAD in this cohort. One hundred and sixty-four (7.5%) patients also underwent OHT during the same admission, which occurred on average 32 d (IQR 7.75-66 d) after LVAD implantation. Of patients who underwent OHT, patients who underwent transplantation within 7 d of LVAD implantation ("early") experienced increased in-hospital mortality (26.8% vs 12.2%, P = 0.0483) compared to patients who underwent transplant after 8 d ("late"). There was no statistically significant difference in age, sex, race, household income, or number of comorbid diagnoses between the early and late groups. Post-transplant length of stay after LVAD implantation was also not significantly different between patients who underwent early vs late OHT. Conclusion: In this cohort of patients who received LVADs, the rate of in-hospital mortality after OHT was lower for patients who underwent late OHT (at least 8 d after LVAD implantation) compared to patients who underwent early OHT. Delayed timing of OHT after LVAD implantation did not correlate with longer hospital stays post-transplant. Competing Interests: Conflict-of-interest statement: Dr. Dipanjan Banerjee reports research support from HeartWare/Medtronic and Thoratec/St. Jude. None of the other listed authors have any disclosures or potential conflicts of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu